We know that many people are experiencing long haul COVID symptoms. As a result, scientists are looking for possible treatments. One of those scientists is Harvard professor and Alzheimer’s expert Dr. Rudy Tanzi who in partnership with Massachusetts General Hospital recently launched a clinical study looking at Nicotinamide Riboside “NR” (FAQs) (Reviews). Should COVID long haulers be optimistic about Dr Tanzi’s human NR study? Chromadex CEO Rob Fried weighed in on this very issue at the Benzinga Small-Cap Conference yesterday:

At the 4 hr 30 min mark of the Benzinga Conference video below:

“Well, Harvard Medical School and Mass General Hospital recently announced they’re doing a study on Tru Niagen (Nicotinamide Riboside) and long haulers.

This is on ClinicalTrials.gov.

This is brand new.

And they’re beginning this study (currently scheduled to start on May 15, 2021).

We have plenty of anecdotal evidence that those long haulers who have experienced COVID are experiencing mitochondrial dysfunction — basically fatigue and cognitive fog.

And we know that elevating NAD speaks directly to fatigue and cognitive fog (NR elevates NAD levels).

By the way, there are 2 studies that have been conducted out of Turkey — Phase 2 and Phase 3 human clinical studies — both made public.

One with 100 COVID symptomatic patients.

And another with 300 symptomatic COVID patients.

When the Remdesivir study was conducted, it revealed statistically significant improvement in the time to recover from symptoms from COVID — approximately 20%-24% time to recover on Remdesivir.

The Turkey study was on a cocktail that included Tru Niagen (Nicotinamide Riboside) — where the time to recover in the Phase 2 study was 30%, and the time to recover in the Phase 3 study was 39%.

Now, we’re (Chromadex) not selling a drug.

So we can’t market this as a drug to treat COVID.

But the data is out there.

The data is available.”

RELATED:

  • FAQs on taking NAD boosting vitamin supplement Nicotinamide Riboside (NR) can be found HERE.
  • NR supplementation may have helped sufferers of these diseases & conditions (Consumer Reviews)

FOLLOW us on Twitter @RaisingNAD